Merck KGaA (MKGAY.PK) said its Executive Board of decided on an outlook until 2014 for the Merck Group.
Assuming an unchanged economic environment and currency exchange rates similar to the 2011 average (EUR/USD = 1.35; EUR/CHF = 1.20), annual sales should rise from 9.91 billion euros in 2011 to a range of approximately 10.350 billion euros to 10.700 billion euros in 2014.
EBITDA pre one-time items should rise from 2.729 billion euros in 2011 to a range of approximately 3 billion euros to 3.200 billion euros in 2014.
Earnings per share, pre one-time, items should be in a range of approximately 8.20 euros to 9.00 euros per share in 2014.
As part of the recently started efficiency program, Merck intends to deliver net cost savings within Merck Serono of 300 million euros by 2014. One-time costs related to Merck Serono will amount to approximately 600 million euros and will be incurred in 2012 through 2014.
For comments and feedback: editorial@rttnews.com